Guided Therapeutics (GTHP) EPS (Basic) Growth (1y) (2011 - 2025)
Guided Therapeutics (GTHP) EPS (Basic) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 92.23% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.97% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.95% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | -24.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.94% |
| Sep 30, 2025 | 20.79% |
| Jun 30, 2025 | 19.80% |
| Mar 31, 2025 | 99.92% |
| Dec 31, 2024 | -33.09% |
| Sep 30, 2024 | 12.90% |
| Jun 30, 2024 | 56.98% |
| Mar 31, 2024 | -40,878.04% |
| Dec 31, 2023 | 83.94% |
| Sep 30, 2023 | 53.97% |
| Jun 30, 2023 | 17.69% |
| Mar 31, 2023 | 61.46% |
| Dec 31, 2022 | -50.14% |
| Sep 30, 2022 | -696.13% |
| Jun 30, 2022 | 56.19% |
| Mar 31, 2022 | 99.88% |
| Dec 31, 2021 | -100.02% |
| Sep 30, 2021 | -100.00% |
| Jun 30, 2021 | 99.98% |
| Mar 31, 2021 | -108.02% |